We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Abdominal Aortic Aneurysms Screening Urged in Seniors

By HospiMedica International staff writers
Posted on 31 Aug 2015
Two-thirds of deaths due to abdominal aortic aneurysm (AAA) rupture occur in people aged 75 and older and screening strategies should be updated to reflect the demographic shift, claims a new study. More...


Researchers at John Radcliffe Hospital (Oxford, United Kingdom) and Oxford University (United Kingdom) conducted a prospective, population‐based study to determine the incidence and outcome of acute AAA events and the impact of screening strategies in a population of 92,728 citizens of the United Kingdom. The researchers also utilized population projections to predict acute AAA incidence rates over the coming two decades, and estimate the likely impact of current and potential alternative screening programs.

The results showed that over a 12-year period (2002–2014), 103 acute AAA events occurred in the study population, representing an incidence rate of 9 per 1,000,000. Nearly 73% of the acute AAA events were in males, with 66% of all events occurring over 75 years of age. After extrapolating the results to the overall population, the researchers concluded that current United Kingdom screening program would prevent 10.7% of incident events, 5.6% of aneurysm-related deaths, and 12% of life years lost due to AAA. An alternative strategy of screening men who smoked at age 65, and then all men again (along with women) at 75 would be much more effective, they suggested.

If such a screening policy would be implemented, it would result in a three- to fourfold increase in the proportion of deaths prevented and reduction in life years lost, owing to the much higher incidence of acute AAA events at ages 75–84, and the higher case fatality at older ages. Another alternative screening strategy, based on patient risk factors, could also prevent more deaths and save more life years over the current model, while also decreasing the number of scans required each year. The study was published on August 19, 2015, in the Journal of the American Heart Association (JAHA).

“Given that two thirds of acute AAA occurred at over 75 years of age, screening older age groups should be considered. Screening nonsmokers at age 65 is likely to have very little impact on AAA event rates,” concluded lead author Dominic Howard, PhD, and colleagues. “If the national UK screening policy was modified, this could result in an almost four-fold increase in the number of deaths prevented, and a three-fold increase in the number of life-years saved compared to the current U.K. strategy.”

An AAA is a localized dilatation of the abdominal aorta exceeding the normal diameter by more than 50%, and is the most common form of aortic aneurysm; approximately 90% occur below the kidneys. The aneurysms can extend to include one or both of the pelvic iliac arteries. The major complication of AAA is rupture, which is life-threatening, as large amounts of blood spill into the abdominal cavity, and can lead to death within minutes.]Mortality of rupture repair in the hospital is 60–90%.

Related Links:

John Radcliffe Hospital
Oxford University



Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Monitoring System
AlarmSense
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image: The thin foetoscope is guided through the abdominal wall to the placenta. Small magnets in its tip react to an externally generated magnetic field, enabling the instrument to be bent with precision. The robotic platform is designed to occlude shared blood vessels in the placenta of twins with twin-to-twin transfusion syndrome. (Image Credit: created with BioRender.com, ETH Zurich)

Robotic Platform Advances Fetoscopic Treatment of Twin-to-Twin Transfusion Syndrome

Twin-to-twin transfusion syndrome is a life-threatening complication in monochorionic twin pregnancies caused by unbalanced placental blood flow. Definitive treatment requires endoscopic laser coagulation... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.